osimertinib
astrazeneca
['adaura']
the #oncoalerttoptweet #esmo22 day 3 tweet the much-waited 4-year data of adaura: mdfs:65.8 m vs 21.9m hr=0.23 hr=0.24 for cns, 2% probability of cns relapse at 3 years with osi qtc prolong in 9% best, 
?? Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees ?? We are #OncoAlert ??